A股異動丨創業慧康逼近漲停 5G遠程會診投入新冠疫情診療
格隆匯2月12日丨創業慧康(300451.SZ)逼近漲停,報25.63元,總市值189.6億元。

日前,中國電信協助協和醫院搭建的5G遠程會診應用系統正式投入使用,成功連接了協和總指揮部和各分指揮部,為高效實施疫情診治助力。此次將5G遠程會診平台投入新型冠狀病毒疫情診治中,減少醫患直接接觸,是5G+智慧醫療的又一落地實施。
未來幾年將是中國智慧醫療建設飛速發展的時期,在新醫改方案的指導下,各地方政府將會加大當地智慧醫療建設方面的投入,將會有更多的醫療機構參與到信息化建設中,一些信息化建設較好的醫療機構也將致力於建設更為先進的醫院管理系統。
創業慧康一直專注於醫療衞生行業的信息化建設業務,主營業務主要包括醫院信息化軟件、公共衞生信息化、計算機信息設備系統集成和智能化網絡佈線工程集成等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.